Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
Stock Snapshot
Regeneron(REGN) stock is priced at $618.95, giving the company a market capitalization of 64.93B. It carries a P/E multiple of 14.69 and pays a dividend yield of 60.4%.
During the trading session on 2026-06-03, Regeneron(REGN) shares reached a daily high of $623.90 and a low of $599.00. At a current price of $618.95, the stock is +3.3% higher than the low and still -0.8% under the high.
Trading volume for Regeneron(REGN) stock has reached 976.07K, versus its average volume of 1.32M.
The stock's 52-week range extends from a low of $476.49 to a high of $821.11.
The stock's 52-week range extends from a low of $476.49 to a high of $821.11.
REGN News
CytomX Therapeutics (CTMX) traded higher in the morning hours on Wednesday after the cancer drug developer announced an expanded collaboration and licensing agr...
CytomX Therapeutics (CTMX) announced an expansion of its collaboration and licensing agreement with Regeneron Pharmaceuticals (REGN) to create conditionally-act...
Regeneron Pharmaceuticals (REGN) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from a...
Analyst ratings
74%
of 31 ratingsMore REGN News
In late May 2026, Regeneron reported three pipeline updates: WHO prioritization of Inmazeb component maftivimab for Bundibugyo Ebola trials, EMA accelerated rev...
Regeneron Pharmaceuticals (REGN) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from a...
Regeneron Pharmaceuticals (REGN) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from a...
Regeneron Pharmaceuticals (REGN) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from a...
Regeneron (REGN) announced that maftivimab, the most potent neutralizing antibody included in Inmazeb, has been recommended by the World Health Organization’s,...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.